Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Former McKinsey boss sounded out over HSBC chair - report

(Sharecast News) - The former head of McKinsey & Company has been sounded out about becoming the new chair of HSBC Holdings, it was reported on Friday. According to Sky News, Kevin Sneader is one of a number of people being considered to replace current incumbent Mark Tucker.

Sneader was voted out as global managing partner of the consulting giant in 2021, after spending three years in the role in Hong Kong. Up until then he had spent his entire career at the firm, starting as a business analysts in the London office in 1989.

The US firm was hit by a number of crisis during his tenure, including having to pay out $600m to 49 US states for its role in advising opioid manufacturers.

Sneader is now at partner at Goldman Sachs and the bank's president of Asia Pacific, excluding Japan.

HSBC's long-serving chair announced last month he was retiring from the board after nearly eight years.

His departure comes as the blue chip looks to radically overhaul its global offering under recently installed chief executive Georges Elhedery, who took over from Noel Quinn last September.

As well as cutting $1.5bn rom the annual cost base by the end of next year, Elhedery wants London-listed HSBC to refocus on Asia, its most important market. As part of that, the lender is cutting its investment banking and equity capital markets offerings in the west.

HSBC said on Friday that Tucker would leave in September, when it will return to AIA - the Hong Kong insurer he used to run - as non-executive chair.

Tucker was the first outsider to become HSBC chair in the bank's 152-year history, Sky noted.

Brendan Nelson, head of the audit committee, will become interim chair while senior independent director Ann Godbehere continues to led the search for a permanent replacement.

Neither HSBC nor Sneader have commented on the Sky report.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.